TY - JOUR
T1 - MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy
AU - Topalian, Suzanne L.
PY - 1994
Y1 - 1994
N2 - Recent studies in human and murine systems suggest a central role for CD4+ T cells in initiating, effecting and maintaining anti-tumor immunity. Characterization of the tumor-associated antigens recognized by CD4+ T cells may prove critical to the success of cancer immunotherapy strategies.
AB - Recent studies in human and murine systems suggest a central role for CD4+ T cells in initiating, effecting and maintaining anti-tumor immunity. Characterization of the tumor-associated antigens recognized by CD4+ T cells may prove critical to the success of cancer immunotherapy strategies.
UR - http://www.scopus.com/inward/record.url?scp=0028003924&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028003924&partnerID=8YFLogxK
U2 - 10.1016/0952-7915(94)90078-7
DO - 10.1016/0952-7915(94)90078-7
M3 - Article
C2 - 7826529
AN - SCOPUS:0028003924
SN - 0952-7915
VL - 6
SP - 741
EP - 745
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 5
ER -